Objective To study how treatment decisions are made alongside the lung cancer clinical
pathway. Methods A prospective, multicentre, multimethods, five-stage, qualitative study …

Purpose The purpose of this study is to review the literature examining how the beliefs and
behaviours of physicians and patients influence clinical communication, doctor–patient …

Objective: Most patients with non-small cell lung cancer (NSCLC) present with an incurable,
advanced disease, and treatment decisions may be hard. This study explored the factors …

Introduction Patient-centred care is essential to the delivery of healthcare; however, this
necessitates direct patient involvement in clinical decision-making and can be challenging …

Background The objective of this study is to investigate the role and experience of early
stage non-small cell lung cancer (NSCLC) patient in decision making process concerning …

OBJECTIVE: To identify preferences of advanced lung cancer patients for receiving
information and participating in decision-making concerning treatment options, health-care …

Introduction The value of shared decision-making and decision aids (DA) has been well
documented yet remain difficult to integrate into clinical practice. We wanted to investigate …

Background Previous studies have investigated patients' treatment goals before starting a
treatment for metastatic lung cancer. Data on the evaluation of treatment goals are lacking …

Objective: To determine how patients with lung cancer value the trade off between the
survival benefit of chemotherapy and its toxicities. Design: Scripted interviews that included …

One more chemo or one too many? The increasing use of expensive cancer treatments
close to the patient's death is often explained by oncologists' failure to communicate to …